to be IC50 ) 2.1 µM for M. aeruginosa, IC50 ) 5.8 µM for
Synechococcus, and IC50 ) 29.1 µM for K. contorta. These
results show the sensitivity of the toxic cyanobacterium M.
aeruginosa to nostocarboline (4).
The conjugate 9 was thus obtained via the known product 8
of the reaction of ciprofloxacin with 1,4-di(chloromethyl)-
benzene13 and subsequent alkylation of 6-Cl-norharmane (1),
shown in Scheme 2. Compound 9 retained the broad activity
Nostocarboline (4) was also tested against the growth of
its producer, Nostoc 78-12A, and showed a pronounced
reduced activity as a MIC value of 50 µM and a high MPC
value of 100 µM were determined. This large difference in
MIC values for autoinhibition (50 µM) to the MPC values
for competing organisms (10 µM) results in sustained growth
of the producing organism with concomitant killing of
competing phytoplankton. Moreover, significant amounts of
nostocarboline (4) were detected in standing cultures of
Nostoc 78-12A by HPLC-MS. Thus, these results point to
the presumed ecological role of nostocarboline (4) by
inducing competitive advantage via secretion.
Scheme 2. Preparation of the Quinolone Carboline Hybrid 9
To elucidate the mode of action of nostocarboline (4),
growth experiments were performed with an initial growth
phase in the dark. Virtually no inhibitory action was observed
in that period for nostocarboline (4) for concentrations of
up to 50 µM, indicating that nostocarboline activity is
correlated to the photosynthesis of M. aeruginosa.3,10 This
notion is supported by the fact that nostocarboline (4) was
not active against the growth of pathogenic nonphotosyn-
thetic bacteria (different strains of Staphylococcus, Entero-
coccus, Pseudomonas, Streptococcus, Haemophilus, Mo-
raxella, Escherichia) and yeast up to concentrations of 93
µM (see also Table 2). This selective inhibitory activity to
of nostocarboline (4) against photoautotrophs and gained
activity against eukaryotic organisms when compared to
ciprofloxacin (Table 1). Moreover, the hybrid 9 displays
antibacterial activity against several Gram-negative strains
(Table 2), whereas the parent nostocarboline (4) was inactive.
However, a loss of 1 to 2 orders of magnitude compared to
ciprofloxacin was observed. Some of this reduced activity
can be explained by efflux phenomena, as the hybrid 9
displayed increased activity against an efflux deficient
Escherichia coli strain (0.7 µM).
In conclusion, nostocarboline and its derivatives 3-7
display potent cyanobacteriocidal and algicidal activity
against photosynthetic aquatic organisms. The benefits of
nostocarboline (4) include (a) potent and fast reduction of
phytoplankton growth, (b) cheap and simple preparation, (c)
the biogenic nature offering benefits in its potential registra-
tion (“natural algicide”), (d) selectivity to photosynthetic
organisms, and (e) a structure which is amenable to easy
modification resulting in more potent derivatives such as 6
or the natural product hybrid 9. For all these reasons,
nostocarboline (4) can thus be considered a promising lead
structure for the development of algicides addressing the
worldwide need for effective, biogenic, and simple antifoul-
ing agents. Current efforts are directed toward the elucidation
of the mode of action of nostocarboline (4), a general
evaluation of its antifouling properties, and the related in
Table 2. Antibacterial Evaluation of Nostocarboline (4), the
Nostocarboline Ciprofloxacin Hybrid 9, and Ciprofloxacina
strainsb
4
hybrid 9
cipro
S. aureus
H. influenzae
M. catarrhalis
E. coli ATCC 25922
E. coli A-337
>93
>93
>93
>93
>93
42.4
10.6
21.2
10.6
0.7
1.5
e0.09
e0.09
e0.09
e0.09
a Values are given in µM. b The strains surveyed were Staphylococcus
aureus ATCC 29213, Haemophilus influenzae A-921, Moraxella catarrhalis
A-894, Escherichia coli ATCC 25922, and Escherichia coli A-337 (TolC
efflux deficient).
photoautotrophs can be rationalized by the structural similar-
ity of nostocarboline (4) to known and potent algicides such
as diuron/monuron or herbicides such as paraquat. Detailed
mechanistic studies on the photosynthesis inhibition of
nostocarboline (4) are thus warranted.
The natural product hybrid11 9 was targeted next, as this
quinolone chimera12 could possess a dual mode of action.
(10) Several cyanobacterial metabolites inhibit photosynthesis in compet-
ing organisms. For examples, see: Hagmann, L.; Ju¨ttner, F. Tetrahedron
Lett. 1996, 36, 6539-6542. Todorova, A. K.; Ju¨ttner, F. J. Org. Chem.
1995, 60, 7891-7895.
(11) Review on natural product hybrids: Tietze, L. F.; Bell, H. P.;
Chandrasekhar, S. Angew. Chem., Int. Ed. 2003, 42, 3996-4028.
(12) For other quinolone chimeras, see, for example: Hubschwerlen, C.;
Specklin, J.-L.; Sigwalt, C.; Schroeder, S.; Locher, H. H. Bioorg. Med.
Chem. 2003, 11, 2313-2319.
(13) The electrophile was prepared according to: Kerns, R. J.; Rybak,
M. J.; Kaatz, G. W.; Vaka, F.; Cha, R.; Grucz, R. G.; Diwadkar, V. U.
Bioorg. Med. Chem. Lett. 2003, 13, 2109-2112.
Org. Lett., Vol. 8, No. 4, 2006
739